OrganiGram (OGI) Investor Presentation summary

Strategic vision and leadership

• Aims to be a respected global leader in cannabis, focused on responsible growth and evolving consumer needs.

• Holds the #1 market share in Canada for recreational cannabis, with leadership in pre-rolls, concentrates, milled flower, vapes, and hash.

• Operates five advanced cultivation, production, and logistics facilities across Canada, supporting coast-to-coast market leadership.

• Rapid international expansion with strong year-over-year growth in global shipments and distribution in key markets including the UK, Germany, and Australia.

• Portfolio includes premium, mainstream, and value brands, delivering broad category coverage.

Operational excellence and innovation

• Facilities feature state-of-the-art technology, including Canada’s largest indoor cultivation and advanced extraction and manufacturing capabilities.

• Seed-based cultivation now accounts for 27% of Moncton harvest, improving cost efficiency and product quality.

• Award-winning brands like SHRED and Edison drive category leadership and innovation, including proprietary fast-acting products.

• Ongoing investments in R&D and technology through partnerships and strategic investments, such as with Phylos Bioscience and Green Tank Technologies.

Strategic acquisitions and investments

• Motif Labs acquisition (Dec 2024) added $87M in sales and is expected to deliver $15M in annual cost synergies, strengthening supply chain and market position.

• Collective Project acquisition (Mar 2025) accelerated entry into the U.S. and Canadian beverage markets, expanding distribution to 25 U.S. states.

• Over $345M invested by BAT, including the $83.1M Jupiter pool for global cannabis opportunities, with $59M still available.

• Strategic investments in Germany (Sanity Group), the U.S. (Open Book Extracts), and seed technology (Phylos) support global expansion and product innovation.